Tue, 09 Dec 2014 12:20:03 GMT ~ Lilly and Incyte Announce Positive Top-Line Results From Phase 3 Trial of Baricitinib in Moderate to Severe Rheumatoid Arthritis
[at noodls] - FIRST OF SEVERAL PHASE 3 TRIALS TO REPORT RESULTS Dec 9, 2014 7:00am INDIANAPOLIS , Dec. 9, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announce that ...
Tue, 09 Dec 2014 12:05:35 GMT ~ Lilly and Incyte Announce Positive Top-Line Results From Phase 3 Trial of Baricitinib in Moderate to Severe Rheumatoid Arthritis
[at noodls] - INDIANAPOLIS, Dec. 9, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announce that the Phase 3 RA-BEACON study of the investigational medicine baricitinib ...
Tue, 09 Dec 2014 12:00:00 GMT ~ Lilly and Incyte Announce Positive Top-Line Results From Phase 3 Trial of Baricitinib in Moderate to Severe Rheumatoid Arthritis
[PR Newswire] - INDIANAPOLIS, Dec. 9, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announce that the Phase 3 RA-BEACON study of the investigational medicine baricitinib ...
Link: http://www.otcmarkets.com/stock/INCY/company-info Ticker: $INCY OTC Market Place: Not Available CIK code: 0000879169 Company name: Incyte Corp. Company website: http://www.incyte.com Incorporated In: DE, USA
$INCY share structure
## source: otcmarkets.com
Market Value: $12,826,065,783 a/o Dec 11, 2014 Shares Outstanding: 168,941,857 a/o Oct 23, 2014 Float: Not Available Authorized Shares: Not Available Par Value: 0.001 $INCY extra dd links
Company name: Incyte Corp. Company website: http://www.incyte.com